GenMark Diagnostics Profit Margin

The latest profit margin for GNMK is -10.87% as of December 2020. That compares with -53.79% in the prior-year period — up 79.8% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside GenMark Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, GNMK's profit margin moved from -53.79% to -10.87% — a 79.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GenMark Diagnostics's valuation or profitability profile.

Against Healthcare companies, GNMK currently prints -10.87% for profit margin, while the sector average sits near 13.89%. That is roughly 178.2% below the sector mean. Large gaps often invite a closer look at GenMark Diagnostics's growth, margins, and balance sheet.

Profit Margin shows how effectively GenMark Diagnostics converts resources into returns. At -10.87%, GNMK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -53.79% in the prior-year period — up 79.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GNMK's profit margin (-10.87%), review year-over-year change from -53.79%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.